Brief: Quotient Limited And Ortho Clinical Diagnostics Settle Arbitration And Sign Binding Letter Of Intent Covering Patient Transfusion Diagnostics

Quotient

08/09/2020 12:39

Sept 8 (Reuters) - Quotient Ltd  QTNT.O :
    * QUOTIENT LIMITED AND ORTHO CLINICAL DIAGNOSTICS SETTLE
ARBITRATION AND SIGN BINDING LETTER OF INTENT COVERING PATIENT
TRANSFUSION DIAGNOSTICS
    * QUOTIENT LTD - LOI ALSO ENDS PENDING ARBITRATION BETWEEN
TWO
COMPANIES
    * QUOTIENT LTD -  LOI ESTABLISHES A NEW DISTRIBUTOR
RELATIONSHIP
FOCUSED SOLELY ON PATIENT TRANSFUSION DIAGNOSTICS
    * QUOTIENT LTD - QUOTIENT WILL DEVELOP AN IMMUNOHEMATOLOGY
(IH)
MOSAIQ™ MICROARRAY OPTIMIZED FOR PATIENT TRANSFUSION MARKET
    * QUOTIENT LTD - IN ADDITION TO PAYMENTS FOR PRODUCTS IT
WILL
SUPPLY, QUOTIENT WILL ALSO BE ENTITLED TO PAYMENTS IN AMOUNT OF
UP TO $67.5 MILLION
    * QUOTIENT LTD - QUOTIENT RETAINS RIGHTS TO MARKET,
DISTRIBUTE AND
SELL IH MICROARRAY FOR USE IN TESTING BLOOD DONORS
    * QUOTIENT LTD - UNDER NEW AGREEMENT ORTHO HAS NO RIGHTS TO
APPLICATIONS OF QUOTIENT'S MOSAIQ TECHNOLOGY OUTSIDE OF PATIENT
TRANSFUSION DIAGNOSTICS
    * QUOTIENT LTD - FIRST NON-REFUNDABLE MILESTONE PAYMENT OF
$7.5
MILLION WAS RECEIVED ON SEPTEMBER 4, 2020

Source text for Eikon:  ID:nGNX4hRQ90 
Further company coverage:  QTNT.O 

 ((Reuters.Briefs@thomsonreuters.com;))